Published in Mediators Inflamm on December 27, 2015
Latin America validation of FACED score in patients with bronchiectasis: an analysis of six cohorts. BMC Pulm Med (2017) 0.75
Neutrophil Elastase Activity is Associated with Exacerbations and Lung Function Decline in Bronchiectasis. Am J Respir Crit Care Med (2016) 0.75
Standardisation of spirometry. Eur Respir J (2005) 48.20
Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J (2005) 5.24
Recommendations for standardized procedures for the on-line and off-line measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide in adults and children-1999. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, July 1999. Am J Respir Crit Care Med (1999) 3.37
British Thoracic Society guideline for non-CF bronchiectasis. Thorax (2010) 2.95
The bronchiectasis severity index. An international derivation and validation study. Am J Respir Crit Care Med (2014) 2.18
Induced sputum cell counts in healthy adults. Am J Respir Crit Care Med (2000) 1.93
Sputum induction. Eur Respir J Suppl (2002) 1.88
Primary care summary of the British Thoracic Society Guideline on the management of non-cystic fibrosis bronchiectasis. Prim Care Respir J (2011) 1.65
Comparison of spontaneous and induced sputum for investigation of airway inflammation in chronic obstructive pulmonary disease. Thorax (1998) 1.64
Effects of long-term azithromycin therapy on airway oxidative stress markers in non-cystic fibrosis bronchiectasis. Respirology (2013) 1.53
The Sputum Colour Chart as a predictor of lung inflammation, proteolysis and damage in non-cystic fibrosis bronchiectasis: a case-control analysis. Respirology (2013) 1.50
Short- and long-term antibiotic treatment reduces airway and systemic inflammation in non-cystic fibrosis bronchiectasis. Am J Respir Crit Care Med (2012) 1.48
Mucosal inflammation in idiopathic bronchiectasis: cellular and molecular mechanisms. Eur Respir J (2008) 1.31
Clinical measures of disease in adult non-CF bronchiectasis correlate with airway microbiota composition. Thorax (2013) 1.28
Multidimensional approach to non-cystic fibrosis bronchiectasis: the FACED score. Eur Respir J (2013) 1.19
The pathophysiology of bronchiectasis. Int J Chron Obstruct Pulmon Dis (2009) 1.18
The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med (2005) 1.13
Determination of malondialdehyde in breath condensate by high-performance liquid chromatography with fluorescence detection. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.10
Validation of the Leicester Cough Questionnaire in non-cystic fibrosis bronchiectasis. Eur Respir J (2009) 1.06
Increases in CD4+ T lymphocytes, macrophages, neutrophils and interleukin 8 positive cells in the airways of patients with bronchiectasis. Thorax (1998) 1.00
Relation of oxidant-antioxidant imbalance with disease progression in patients with asthma. Ann Thorac Med (2012) 0.93
Exhaled H(2)O(2) in steady-state bronchiectasis: relationship with cellular composition in induced sputum, spirometry, and extent and severity of disease. Chest (2002) 0.91
Malondialdehyde in exhaled breath condensate as a marker of oxidative stress in different pulmonary diseases. Mediators Inflamm (2011) 0.89
Matrix metalloproteinases vary with airway microbiota composition and lung function in non-cystic fibrosis bronchiectasis. Ann Am Thorac Soc (2015) 0.86
Induced sputum is a reproducible method to assess airway inflammation in asthma. Mediators Inflamm (2002) 0.86
Association between inflammatory markers in induced sputum and clinical characteristics in children with non-cystic fibrosis bronchiectasis. Pediatr Pulmonol (2007) 0.86
Prevalence of bronchiectasis in asthma according to oral steroid requirement: influence of immunoglobulin levels. Biomed Res Int (2013) 0.83
Increase in markers of airway inflammation after ozone exposure can be observed also in stable treated asthmatics with minimal functional response to ozone. Respir Res (2010) 0.80
Imaging of bronchiectasis. Clin Chest Med (2012) 0.78